Stockreport

Melinta Therapeutics Provides for Distribution of Delafloxacin to 19 Countries via Extended Agreement with Eurofarma Laboratórios

CEMPRA  (CEMP) 
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF NEW HAVEN, Conn., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held commercial-stage company developing novel antibiotics to treat serious bact [Read more]